EUVIMEDEUVIMED entdecken
Crossref

The Burden of Erythropoietic Protoporphyria ( EPP ): Results From the EPP Life Impact and Genetic Health Trajectory ( LIGHT ) Study

Hetanshi Naik iD, Manisha Balwani iD, Hilary H Colwell, Susan D Mathias iD, Kristen Wheeden, Chelsea Norregaard, Melanie Chin, William Savage

The Journal of Dermatology · 2025-10 · 52 (10) · 1576-1583

DOI: 10.1111/1346-8138.17897 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Dermatology, online erschienen am 09.08.2025. Verfasst von Hetanshi Naik und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Genetics, Stanford University, Stanford, California, USA. Hauptthemen laut MEDLINE: Protoporphyria, Erythropoietic, Quality of Life, Cost of Illness. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 25 Literaturangaben. Gefördert von: Disc Medicine.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Erythropoietic protoporphyria (EPP) and X‐linked protoporphyria (XLP) are rare metabolic disorders causing phototoxicity, potential liver damage, and significant burden in all facets of life. We sought to quantify symptoms, health‐related quality of life (HRQoL), work/school productivity, and healthcare utilization (HCU) of individuals with protoporphyria using the EPP Life Impact and Genetic Health Trajectory (LIGHT) study. A cross‐sectional, online questionnaire administered to 164 adults and 33 adolescents with protoporphyria aged ≥ 12 years, included validated patient‐reported outcome measures and original items assessing symptoms, HRQoL, productivity, and HCU. Prodromal (early warning) symptoms after sunlight exposure, reported by > 50% of participants, included tingling, warmth, itching, sensitivity to touch, and burning; symptoms occurred in ≤ 10 min in 48.8% of adults and 15.2% of adolescents. Symptoms hindered daily activities at least “somewhat” for 62.8% of adults and 87.9% of adolescents, and 23.4% ‐ 41.7% reported school/work absenteeism in past month; 67.1% of adults and 87.9% of adolescents experienced ≥ 1 phototoxic reaction in the previous 12 months. Most adults and adolescents reported feeling depressed (75.0%, 45.5%), anxious (79.9%, 60.6%), isolated (82.9%, 57.6%), frustrated (90.2%, 93.9%), and lonely (75.6%, 39.4%). Fifty‐four percent (53.7%; adults) and 16.7% (adolescents) reported work productivity was affected by their EPP at least “a little bit.” Adults had a mean number of eight physician visits related to EPP in the previous 12 months, and adolescents had a mean number of 3.2 visits. Adults averaged 5.5 emergency room visits annually. Protoporphyria significantly affects daily life through symptoms, emotional/psychological distress, and HCU.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Protoporphyria, ErythropoieticQuality of LifeCost of IllnessHumansMaleFemaleAdultCross-Sectional StudiesAdolescentYoung AdultMiddle AgedSunlightChildPatient Acceptance of Health CareAbsenteeismProdromal SymptomsEfficiencyAgedPatient Reported Outcome MeasuresSurveys and Questionnaires

Stichwörter der Autor:innen

erythropoietic protoporphyria (EPP)healthcare utilizationhealth‐related quality of lifepatient‐reported outcomesphototoxicity

Autor:innen und Institutionen

  • Department of Genetics, Stanford University, Stanford, California, USA.
  • Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
  • Health Outcomes Solutions, Palm Beach Gardens, Florida, USA.
  • United Porphyrias Association, Bethesda, Maryland, USA.
  • Disc Medicine, Watertown, Massachusetts, USA.

ORCID-Profile: Hetanshi Naik, Manisha Balwani, Susan D Mathias

Förderung

  • Disc Medicine

Zitieren

APA

Naik, H., Balwani, M., Colwell, H. H., Mathias, S. D., Wheeden, K., Norregaard, C., Chin, M., & Savage, W. (2025). The Burden of Erythropoietic Protoporphyria ( EPP ): Results From the EPP Life Impact and Genetic Health Trajectory ( LIGHT ) Study. The Journal of Dermatology, 52(10), 1576-1583. https://doi.org/10.1111/1346-8138.17897

Vancouver

Naik H, Balwani M, Colwell HH, Mathias SD, Wheeden K, Norregaard C, et al. The Burden of Erythropoietic Protoporphyria ( EPP ): Results From the EPP Life Impact and Genetic Health Trajectory ( LIGHT ) Study. The Journal of Dermatology. 2025;52(10):1576-1583. doi:10.1111/1346-8138.17897

BibTeX
@article{Naik2025,
  author = {Naik, Hetanshi and Balwani, Manisha and Colwell, Hilary H and Mathias, Susan D and Wheeden, Kristen and Norregaard, Chelsea and Chin, Melanie and Savage, William},
  title = {The Burden of Erythropoietic Protoporphyria ( EPP ): Results From the EPP Life Impact and Genetic Health Trajectory ( LIGHT ) Study},
  journal = {The Journal of Dermatology},
  year = {2025},
  volume = {52},
  number = {10},
  pages = {1576--1583},
  doi = {10.1111/1346-8138.17897}
}
Kostenlos starten →